Malibu Life Holdings Limited financials
Malibu Life Holdings Limited
549300WXTCG65AQ7V644 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | $57.8M | $0 |
| Other income | $2.3M | $2.9M |
| Administrative expenses | $287.6K | $130.3K |
| Profit before tax | $25.0M | $114.3M |
| Income tax expense | $3.6M | $0 |
| Profit for the year | $21.4M | $114.3M |
| Total comprehensive income | $23.6M | $114.3M |
| Per share | ||
| Basic EPS | $1.23 | $0.00 |
| Diluted EPS | $1.23 | $0.00 |
| Cash flow statement | ||
| Net cash from operating activities | $51.1M | $59.6K |
| Net cash from investing activities | $38.9M | $0 |
| Net cash from financing activities | -$63.2M | $0 |
| Balance sheet | ||
| Total assets | $1.93B | $569.1M |
| Cash & equivalents | $16.2M | $250.2K |
| Total equity | $569.0M | $567.1M |
| Deferred tax liabilities | $3.7M | $0 |
| Derived metrics | ||
| Net margin | 37.0% | — |
| Return on equity | 3.8% | 20.2% |
| Cash conversion ratio | 2.39× | 0.00× |
| Other reported items | ||
| Accumulated Other Comprehensive Income | $2.2M | — |
| Adjustments For Decrease Increase In Loans and Advances | $13.2K | -$648 |
| Adjustments For Decrease Increase In Other Assets | -$1.5M | $33.2K |
| Cash and Cash Equivalents If Different From Statement of Financial Position | $27.1M | $250.2K |
| Directors Remuneration Expense | $1.2M | $454.0K |
| Dividends Classified As Expense | $1.3M | $1.9M |
| Equity and Liabilities | $1.93B | $569.1M |
| Expense By Nature | $70.6M | $4.0M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | $944.1K | -$297.0K |
| Increase Decrease In Cash and Cash Equivalents | $26.9M | $59.6K |
| Interest Expense | $6.7M | $13.8M |
| Investments Other Than Investments Accounted For Using Equity Method | $441.6M | $549.2M |
| Issue of Equity | $123.5M | — |
| Issued Capital | $0 | — |
| Liabilities | $1.36B | $2.0M |
| Loans and Receivables | $0 | $13.2K |
| Other Assets | $1.6M | $48.2K |
| Other Comprehensive Income | $2.2M | $0 |
| Other Expense By Function | $1.4M | $2.7M |
| Other Fee and Commission Expense | $7.9M | $3.3M |
| Payments To Acquire Or Redeem Entitys Shares | $125.0M | $0 |
| Proceeds From Disposal Or Maturity of Availableforsale Financial Assets | $3.7M | $0 |
| Proceeds From Issuing Shares | $61.9M | $0 |
| Proceeds From Sales of Investments Accounted For Using Equity Method | $47.0M | $0 |
| Purchase of Availableforsale Financial Assets | $15.7M | $0 |
| Restricted Cash and Cash Equivalents | $10.9M | $0 |
| Retained Earnings | $7.6M | — |
| Revenue From Dividends | $2.1M | $3.2M |
| Revenue From Interest | $8.1M | $24.2M |
| Trade and Other Receivables | $2.0M | $3.3M |
Every line item above is a fact tagged in Malibu Life Holdings Limited's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.